Verizon stock slips below $40 as Wall Street rallies; dividend and Jan. 30 earnings in focus

Verizon stock slips below $40 as Wall Street rallies; dividend and Jan. 30 earnings in focus

New York, January 5, 2026, 14:39 EST — Regular session

  • Verizon shares fell about 1.3% in afternoon trading, underperforming major U.S. wireless peers.
  • Verizon rolled out new Verizon Access promotions tied to Super Bowl LX and FIFA World Cup 2026.
  • Investors are watching the Jan. 12 ex-dividend date and the Jan. 30 earnings report, with U.S. payrolls due Friday.

Verizon Communications Inc. shares fell about 1.3% to $39.99 in afternoon trading on Monday.

The dip stands out because Verizon is widely owned as a defensive, income-oriented stock. In a risk-on session — when investors favor higher-risk assets — money can rotate away from dividend payers. Reuters

The stock faces two near-term markers: Verizon’s Jan. 12 ex-dividend date and its Jan. 30 quarterly earnings report. Traders also have Friday’s U.S. monthly nonfarm payrolls report on the radar for clues on the path of interest rates. Verizon

Wall Street’s main indexes climbed after a U.S. military strike captured Venezuelan President Nicolas Maduro, lifting energy shares and big banks, Reuters reported. “We’re seeing a risk on mood,” said Steve Sosnick, chief market analyst at Interactive Brokers. Reuters

Verizon added fresh consumer-facing headlines on Monday. The company said its “Ultimate Super Bowl LX Experience” sweepstakes opens Jan. 9 and runs through Jan. 18, with additional ticket drops for Verizon Access members in the My Verizon app on Jan. 9-11. Verizon

A separate Verizon release said the carrier and David Beckham will offer FIFA World Cup 2026 ticket drops from Jan. 7-11 at 3 p.m. ET daily, also through Verizon Access. The company said tickets will be claimed on a first-come, first-served basis. Verizon

By contrast, AT&T shares were up about 0.3% and T-Mobile gained about 1% on Monday. Verizon traded between $39.85 and $40.56 so far in the session.

Verizon said it will report fourth-quarter 2025 earnings on Jan. 30 and host a webcast starting at 8 a.m. ET. Investors typically focus on wireless subscriber trends and free cash flow — cash left after operating costs and capital spending — because it underpins dividends and debt reduction. Verizon

The setup cuts both ways. Any sign that promotions are intensifying, or that subscriber trends are softening, can compress margins, while a shift in rate expectations after Friday’s payrolls data could sway dividend-heavy stocks. Markets are pricing about 60 basis points, or 0.60 percentage point, of rate cuts this year, LSEG data cited by Reuters showed. Reuters

Verizon’s board declared a quarterly dividend of 69 cents per share payable on Feb. 2 to shareholders of record at the close of business on Jan. 12. The stock is scheduled to trade ex-dividend on Jan. 12 — the date after which buyers are no longer entitled to that payout. Verizon

For Verizon investors, the next major catalyst is Jan. 30, when management will update guidance and take questions on competitive intensity across U.S. wireless and broadband. Verizon

Stock Market Today

  • CVS Dividend Run Watch: Ex-Dividend Date and Payout Dynamics
    January 7, 2026, 11:02 AM EST. CVS Health Corp is drawing notice from DividendChannel.com's Dividend Alerts service for a potential 'Dividend Run' ahead of its ex-dividend date. The ex-dividend date is the first day a stock trades without the right to the upcoming dividend; buyers on or after that date are not eligible to receive it. Typically, the share price drops by the dividend amount on the ex-date, all else equal, but some investors expect a pre-dividend run as buyers bid up shares in anticipation. Strategies vary: some buy before ex-dividend and sell after to capture the payout; others purchase two weeks prior to the targeted exit. For CVS, the dividend cited is 0.665 per share, with the ex-dividend date noted as 10/23/25.
Accenture stock rebounds nearly 2% as Redburn nudges target; dividend date and March earnings in focus
Previous Story

Accenture stock rebounds nearly 2% as Redburn nudges target; dividend date and March earnings in focus

BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms
Next Story

BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms

Go toTop